Nika Pharmaceuticals, Inc Liquidation Value
NIKA
Other
Cash & Equivalents
$1,889
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $1,889
Total Obligations: -$318,624
$-316,735
Per share: $-0.00
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $1,889
AR: $0
Total Obligations: -$318,624
$-316,735
Per share: $-0.00
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $1,889
AR: $0
Inventory: $0
Total Obligations: -$318,624
$-316,735
Per share: $-0.00
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-316,735 | $-0.00 |
| Liquid Liquidation Value | $-316,735 | $-0.00 |
| Operating Liquidation Value | $-316,735 | $-0.00 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1,889 |
| Accounts Receivable | $196,394 |
| Inventory | $14,104 |
| Current Liabilities | $318,624 |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 1.05B |
Explore all 51 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1,889 | N/A | N/A | N/A | $318,624 | N/A | N/A | N/A |
| 2025-09-30 | $6,287 | N/A | N/A | N/A | $284,164 | N/A | N/A | N/A |
| 2025-06-30 | $15,616 | N/A | N/A | N/A | $284,164 | N/A | N/A | N/A |
| 2025-03-31 | $19,137 | N/A | N/A | N/A | $269,164 | N/A | N/A | N/A |
| 2024-12-31 | $2,083 | N/A | N/A | N/A | $239,164 | N/A | N/A | N/A |
| 2024-09-30 | $1,386 | N/A | N/A | N/A | $210,164 | N/A | N/A | N/A |
| 2024-06-30 | $7,486 | $196,394 | $14,104 | N/A | $636,934 | N/A | N/A | N/A |
| 2024-03-31 | $24,466 | N/A | $17,007 | N/A | $265,955 | N/A | N/A | N/A |
▼ Community Notes